Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen: a prospective cohort study

OBJECTIVE: Recycling tenofovir and lamivudine/emtricitabine (XTC) with dolutegravir would provide a more tolerable, affordable, and scalable second-line regimen than dolutegravir with an optimized nucleoside reverse transcriptase inhibitor (NRTI) backbone. We evaluated efficacy of tenofovir/lamivudi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS
Main Authors: Keene, Claire M, Griesel, Rulan, Zhao, Ying, Gcwabe, Zimasa, Sayed, Kaneez, Hill, Andrew, Cassidy, Tali, Ngwenya, Olina, Jackson, Amanda, Van Zyl, Gert, Schutz, Charlotte, Goliath, Rene, Flowers, Tracy, Goemaere, Eric, Wiesner, Lubbe, Simmons, Bryony, Maartens, Gary, Meintjes, Graeme
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7612028/
https://ncbi.nlm.nih.gov/pubmed/33973876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000002936
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados